Skip to main content

Table 2 MIC range, MIC50, and MIC90 of 10 antimicrobial agents against 25 B. melitensis strains

From: Epidemiologically characteristics of human brucellosis and antimicrobial susceptibility pattern of Brucella melitensis in Hinggan League of the Inner Mongolia Autonomous Region, China

Antibiotic

MIC (μg/ml)

Classification of isolates, 1No. (%)

Breakpoints (μg/ml)

Range

50%†

90%†

S

I

R

S

I

R

Doxycycline

0.12–0.24

0.12

0.12

25 (100)

0

0

≤ 1

–

–

Tetracycline

0.25–1

0.25

0.5

25 (100)

0

0

≤ 1

–

–

Gentamicin

0.5–1

0.5

1.0

25 (100)

0

0

≤ 4

–

–

Ciprofloxacin

0.5–1

0.5

1.0

25 (100)

0

0

≤ 1

–

–

Ofloxacin

1.0

1.0

1.0

25 (100)

0

0

≤ 2

–

–

Moxifloxacin

1.0

1.0

1.0

25 (100)

0

0

≤ 1

–

–

Streptomycin

2–4

2.0

4.0

25 (100)

0

0

≤ 8

–

–

Rifampin

0.08–3.2

0.5

1.0

21 (84)

4 (16)

0

≤ 1

2

≥ 4

Cotrimoxazole

1/19–4/76

2/38

4/76

20 (80)

0

5 (20)

≤ 2/38

–

–

Azithromycin

16–64

64

64

0

0

25 (100)

≤ 4

–

–

  1. Note: S susceptible, I intermediate susceptibility, R resistant, 1No. number of isolates
  2. †50 and 90%, MIC at which 50 and 90% of the isolates are inhibited. −: Not determined
  3. Cotrimoxazole: Trimethoprim/sulfamethoxazole (only the trimethoprim portion of the 1/19 drug ratio is displayed)
  4. Breakpoints for slow-growing bacteria according to CLSI recorded for Haemophilus spp. were provided